These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 16702800)
21. Achievement of LDL-cholesterol goal with statins after an st segment elevation myocardial infarction. Tungsubutra W; Phongtuntakul B J Med Assoc Thai; 2015 Feb; 98(2):129-36. PubMed ID: 25842792 [TBL] [Abstract][Full Text] [Related]
24. Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins. Andrews TC; Ballantyne CM; Hsia JA; Kramer JH Am J Med; 2001 Aug; 111(3):185-91. PubMed ID: 11530028 [TBL] [Abstract][Full Text] [Related]
25. Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy. Semb AG; van Wissen S; Ueland T; Smilde T; Waehre T; Tripp MD; Frøland SS; Kastelein JJ; Gullestad L; Pedersen TR; Aukrust P; Stalenhoef AF J Am Coll Cardiol; 2003 Jan; 41(2):275-9. PubMed ID: 12535822 [TBL] [Abstract][Full Text] [Related]
26. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). Jones PH; Davidson MH; Stein EA; Bays HE; McKenney JM; Miller E; Cain VA; Blasetto JW; Am J Cardiol; 2003 Jul; 92(2):152-60. PubMed ID: 12860216 [TBL] [Abstract][Full Text] [Related]
27. Serum from hypercholesterolemic patients treated with atorvastatin or simvastatin inhibits cultured human smooth muscle cell proliferation. Arnaboldi L; Guzzetta M; Pazzucconi F; Radaelli G; Paoletti R; Sirtori CR; Corsini A Pharmacol Res; 2007 Dec; 56(6):503-8. PubMed ID: 17959387 [TBL] [Abstract][Full Text] [Related]
28. High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial. Päivä H; Thelen KM; Van Coster R; Smet J; De Paepe B; Mattila KM; Laakso J; Lehtimäki T; von Bergmann K; Lütjohann D; Laaksonen R Clin Pharmacol Ther; 2005 Jul; 78(1):60-8. PubMed ID: 16003294 [TBL] [Abstract][Full Text] [Related]
29. Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice. Ohsfeldt RL; Gandhi SK; Fox KM; Stacy TA; McKenney JM Am J Manag Care; 2006 Nov; 12(15 Suppl):S412-23. PubMed ID: 17112329 [TBL] [Abstract][Full Text] [Related]
30. Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States. Foody JM; Joyce AT; Rudolph AE; Liu LZ; Benner JS Clin Ther; 2008 Jan; 30(1):195-205. PubMed ID: 18343257 [TBL] [Abstract][Full Text] [Related]
31. Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study. Schuster H; Barter PJ; Stender S; Cheung RC; Bonnet J; Morrell JM; Watkins C; Kallend D; Raza A; Am Heart J; 2004 Apr; 147(4):705-13. PubMed ID: 15077101 [TBL] [Abstract][Full Text] [Related]
32. A comparative study of atorvastatin and simvastatin as monotherapy for mixed hyperlipidaemia in Type 2 diabetic patients. Chan WB; Ko GT; Yeung VT; Osaki R; Ma RC; So WY; Chow CC Diabetes Res Clin Pract; 2004 Oct; 66(1):97-9. PubMed ID: 15364167 [No Abstract] [Full Text] [Related]
34. Atorvastatin, etidronate, or both in patients at high risk for atherosclerotic aortic plaques: a randomized, controlled trial. Kawahara T; Nishikawa M; Kawahara C; Inazu T; Sakai K; Suzuki G Circulation; 2013 Jun; 127(23):2327-35. PubMed ID: 23658438 [TBL] [Abstract][Full Text] [Related]
36. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial. Illingworth DR; Crouse JR; Hunninghake DB; Davidson MH; Escobar ID; Stalenhoef AF; Paragh G; Ma PT; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB; Curr Med Res Opin; 2001; 17(1):43-50. PubMed ID: 11464446 [TBL] [Abstract][Full Text] [Related]
37. A model to assess the cost effectiveness of statins in achieving the UK National Service Framework target cholesterol levels. Wilson K; Marriott J; Fuller S; Lacey L; Gillen D Pharmacoeconomics; 2003; 21 Suppl 1():1-11. PubMed ID: 12648030 [TBL] [Abstract][Full Text] [Related]
38. High-density lipoprotein cholesterol and triglyceride response with simvastatin versus atorvastatin in familial hypercholesterolemia. Wierzbicki AS; Lumb PJ; Chik G; Crook MA Am J Cardiol; 2000 Sep; 86(5):547-9, A9. PubMed ID: 11009276 [TBL] [Abstract][Full Text] [Related]